## **Core Concept**
The tumor lysis syndrome (TLS) is a life-threatening complication often seen in patients with rapidly proliferating malignancies, such as acute leukemias and lymphomas. It results from the massive release of intracellular contents into the bloodstream, leading to hyperuricemia, hyperphosphatemia, hypocalcemia, and hyperkalemia, which can cause acute kidney injury (AKI). The return of renal function in such patients can be predicted by assessing certain parameters.

## **Why the Correct Answer is Right**
The correct answer, **Fractional Excretion of Sodium (FeNa)**, is a useful test in this context. FeNa helps differentiate between prerenal AKI and intrinsic renal causes. In prerenal AKI, which is common in TLS due to volume depletion and uric acid nephropathy, the kidneys avidly reabsorb sodium, leading to a low FeNa (<1%). A FeNa <1% suggests that the kidneys are responding appropriately to volume depletion and have a good chance of recovering function with fluid resuscitation and management of electrolytes. This makes FeNa a helpful predictor of the return of renal function in TLS patients. ## **Why Each Wrong Option is Incorrect** - **Option A:** This option is incorrect because, although serum creatinine levels indicate renal function, they do not predict the return of renal function. - **Option B:** This option is incorrect as it does not directly relate to a commonly used test for predicting renal recovery in TLS. - **Option C:** While urine output is a critical indicator of renal function, it is not a specific test for predicting the return of renal function in TLS. ## **Clinical Pearl / High-Yield Fact** A key clinical pearl is that a FeNa <1% in the setting of AKI often indicates a prerenal cause, which has a better prognosis for renal recovery with appropriate management. This is particularly relevant in TLS, where early intervention can significantly impact outcomes. ## **Correct Answer:** . **Fractional Excretion of Sodium (FeNa)**